Evidence map›Paper›PMID 40827349›Full record

ArticleBiochemical Society transactions2025

Control of epithelial homeostasis by apical polarity: it takes a network.

Sophie A Lelièvre, Joséphine Briand

Abstract read
In one paragraph

Article in Biochemical Society transactions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sophie A LelièvreRelation Genes-Environment (REGEN) Unit, Department of Translational Research, Institut de Cancérologie de l'Ouest (ICO), Angers, Pays de la Loire, 49055, France.ORCID 0000-0001-6606-2501
Joséphine BriandRelation Genes-Environment (REGEN) Unit, Department of Translational Research, Institut de Cancérologie de l'Ouest (ICO), Angers, Pays de la Loire, 49055, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The maintenance of cell functions in response to various stimuli is fulfilled by tightly controlled homeostatic processes. The basoapical structure of normal epithelia is increasingly recognized as the guardian of homeostasis. It has recently been demonstrated that apical polarity, depicted by lateroapical tight junctions, is controlled by gap junctions and sets the resting membrane potential, itself essential for homeostasis, in the breast luminal epithelium. In the breast, the disruption of apical polarity is recognized as a necessary step toward cancer onset, which calls for a better understanding of its consequences on the mechanisms of homeostasis all the way to the genome. Here, we extend the traditional apical junctional complex to include gap junctions and investigate its relation with epigenetically- driven and higher order chromatin organization. The disruption of apical polarity affects different types of molecular networks that remodel chromatin with a tendency toward openness or relaxation, a status typically associated with instability and cancer onset. Events known to foster the development of cancers, such as chronic inflammation, oxidative stress, stiffer microenvironment, and aging, are all triggering the disruption of apical polarity, which leads us to explore possibilities to re-establish full polarity. Focusing on gap junction intercellular communication mediated by Connexin 43 might be an interesting therapeutic option for retinoic acid derivatives. However, in light of the different degrees of apical polarity loss, we surmise that the resulting chromatin alterations might depend on the way apical polarity is disrupted initially, which suggests that therapeutic combinations targeted also toward these alterations might be required.

Indexed as

apical junctional complexbreast cancer riskConnexin 43gap junctionhigher order chromatin organizationprimary prevention

Identifiers

PMID40827349
PMCPMC12493189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.